FIGURE 3.
Kaplan–Meier survival curves of patients with pancreatic cancer according to KRAS mutation status. (A) Disease‐free survival by KRAS mutations. (B) Overall survival by KRAS mutations. (C) Disease‐free survival by variant allele frequency (VAF) of KRAS among KRAS‐mutant tumors. (D) Overall survival by KRAS VAF among KRAS‐mutant tumors